Peng Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Peng Shi has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Junbo Gong
State Key Laboratory of Chemical Engineering School of Chemical Engineering and Technology Tianjin University Tianjin China
15 shared publications - Shijie Xu
Tianjin Key Laboratory of Brine Chemical Engineering and Ecological Utilization of Resources, Tianjin Engineering Center of Marine Chemical Engineering & Technology, Tianjin Key Laboratory of Multiplexed Identification for Port Hazardous Chemicals, College of Chemical Engineering and Materials Science, Tianjin University of Science and Technology, Tianjin 300457, China
10 shared publications - Shichao Du
School of Pharmaceutical Sciences (Shandong Analysis and Test Center), Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China
9 shared publications - Weiwei Tang
School of Chemical Engineering and Technology State Key Laboratory of Chemical Engineering and Low‐Carbon Technology Tianjin University; The Co‐Innovation Centre of Chemistry and Chemical Engineering of Tianjin Tianjin China
9 shared publications Mengmeng Sun
School of Chemical Engineering, Tianjin University, Tianjin 300072, China
4 shared publicationsPanpan Sun
State Key Laboratory of Chemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
4 shared publications
Latest Publications
- Open Access
- 20 August 2021
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 8 (5) , 814-822
Template design based on molecular and crystal structure similarity to regulate conformational polymorphism nucleation: the case of α,ω-alkanedicarboxylic acids
Template design on polymorph control, especially conformational polymorphs, is still in its infancy and the result of polymorph control is often accidental. A method of regulating the crystallization of conformational polymorphs based on the crystal structure similarity of templates and the target crystal form has been developed. Crystal structure similarity was considered to be able to introduce lattice matching (geometric term) with chemical interactions to regulate conformational polymorph nucleation. The method was successfully applied to induce the crystallization of DA7-II [HOOC–(CH2)n−2–COOH (diacids), named DAn, wheren= 7, 9, 15, 17 and II represents the metastable polymorph] on the surface of DA15-II. An analogous two-dimensional plane – the (002) face of both DA15-II and DA7-II – was firstly predicted as the epitaxially attached face with similar lattice parameters and the strongest adsorption energy. The powder DA15-II template with the preferred orientation face in (002) presented much stronger inducing DA7-II ability than the template with other preferred orientation faces. The epitaxial growth of DA7-II on DA15-II through an identical (002) face was clearly observed and verified by the single-crystal inducing experiments. The molecular dynamics simulation results demonstrated that the strong interactions occurred between DA7 molecules and the (002) face of DA15-II. This method has been verified and further applied to the crystallization of DA7-II on the surface of DA17-II and DA9-II on the surface of DA15-II. This study developed a strategy based on structure similarity to regulate the conformational polymorph and verified the significant role of lattice matching and chemical effects on the design and preparation of templates.
- 20 August 2021
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 8 (5) , 814-822
Open AccessTemplate design based on molecular and crystal structure similarity to regulate conformational polymorphism nucleation: the case of α,ω-alkanedicarboxylic acids
Template design on polymorph control, especially conformational polymorphs, is still in its infancy and the result of polymorph control is often accidental. A method of regulating the crystallization of conformational polymorphs based on the crystal structure similarity of templates and the target crystal form has been developed. Crystal structure similarity was considered to be able to introduce lattice matching (geometric term) with chemical interactions to regulate conformational polymorph nucleation. The method was successfully applied to induce the crystallization of DA7-II [HOOC–(CH2)n−2–COOH (diacids), named DAn, wheren= 7, 9, 15, 17 and II represents the metastable polymorph] on the surface of DA15-II. An analogous two-dimensional plane – the (002) face of both DA15-II and DA7-II – was firstly predicted as the epitaxially attached face with similar lattice parameters and the strongest adsorption energy. The powder DA15-II template with the preferred orientation face in (002) presented much stronger inducing DA7-II ability than the template with other preferred orientation faces. The epitaxial growth of DA7-II on DA15-II through an identical (002) face was clearly observed and verified by the single-crystal inducing experiments. The molecular dynamics simulation results demonstrated that the strong interactions occurred between DA7 molecules and the (002) face of DA15-II. This method has been verified and further applied to the crystallization of DA7-II on the surface of DA17-II and DA9-II on the surface of DA15-II. This study developed a strategy based on structure similarity to regulate the conformational polymorph and verified the significant role of lattice matching and chemical effects on the design and preparation of templates.
- Open Access
- 8 May 2021
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 8 (4) , 584-594
Distinct pathways of solid-to-solid phase transitions induced by defects: the case of DL-methionine
Understanding of solid-to-solid phase transition mechanisms in polymorphic systems is of critical importance for rigorous control over polymorph purity in the pharmaceutical industry to achieve the desired bioavailability and efficacy of drugs. Ubiquitous defects in crystals may play an important role in the pathways of phase transitions. However, such effects remain poorly understood. Here, the effects of crystal defects on the solid-to-solid phase transformations between DL-methionine polymorphs α and β are investigated by means of experimental and computational approaches. Thermal analyses of polycrystalline powders show two endothermic peaks in the α-to-β phase transition (and two exothermic peaks for the reverse transition), in contrast with one thermal event observed for single crystals. Variable-temperature 1D and 2D Raman spectra, as well as powder X-ray diffraction patterns, reveal the appearance of two peaks that can attributed to a two-step phase transition, and the extent of the second-step phase transition increases with milling time (or defect density). Quantification of transition kinetics unveils a remarkably higher energy barrier in the second-step phase transition than in the first, proceeding by the cooperative molecular motion pathway. The good linear fitting on the kinetic data by the Jeziorny model suggests that the second-step transition follows the nucleation and growth mechanism. Molecular dynamics simulations were also conducted to understand the role of crystal defects in the solid-state phase transition by tracking the atomic distribution and hydrogen bond lifetime during the transition. It was found that the increasing defect density hinders the propagation of cooperative molecular motion, leading to a combined transition mechanism involving both cooperative motion and nucleation and growth. This study highlights the significant impact of crystal defects on solid-state phase transitions, and the two-step transition mechanism postulated may be universal given the ubiquitous presence of defects in crystalline materials.
- 8 May 2021
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 8 (4) , 584-594
Open AccessDistinct pathways of solid-to-solid phase transitions induced by defects: the case of DL-methionine
Understanding of solid-to-solid phase transition mechanisms in polymorphic systems is of critical importance for rigorous control over polymorph purity in the pharmaceutical industry to achieve the desired bioavailability and efficacy of drugs. Ubiquitous defects in crystals may play an important role in the pathways of phase transitions. However, such effects remain poorly understood. Here, the effects of crystal defects on the solid-to-solid phase transformations between DL-methionine polymorphs α and β are investigated by means of experimental and computational approaches. Thermal analyses of polycrystalline powders show two endothermic peaks in the α-to-β phase transition (and two exothermic peaks for the reverse transition), in contrast with one thermal event observed for single crystals. Variable-temperature 1D and 2D Raman spectra, as well as powder X-ray diffraction patterns, reveal the appearance of two peaks that can attributed to a two-step phase transition, and the extent of the second-step phase transition increases with milling time (or defect density). Quantification of transition kinetics unveils a remarkably higher energy barrier in the second-step phase transition than in the first, proceeding by the cooperative molecular motion pathway. The good linear fitting on the kinetic data by the Jeziorny model suggests that the second-step transition follows the nucleation and growth mechanism. Molecular dynamics simulations were also conducted to understand the role of crystal defects in the solid-state phase transition by tracking the atomic distribution and hydrogen bond lifetime during the transition. It was found that the increasing defect density hinders the propagation of cooperative molecular motion, leading to a combined transition mechanism involving both cooperative motion and nucleation and growth. This study highlights the significant impact of crystal defects on solid-state phase transitions, and the two-step transition mechanism postulated may be universal given the ubiquitous presence of defects in crystalline materials.
- Open Access
- 6 February 2021
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 8 (2) , 161-167
Use of additives to regulate solute aggregation and direct conformational polymorph nucleation of pimelic acid
Understanding the nucleation pathway and achieving regulation to produce the desired crystals are mutually beneficial. The authors previously proposed a nucleation pathway of conformational polymorphs in which solvation and solute self-assembly could affect the result of the conformational rearrangement and further nucleation outcomes. Based on this, herein α,ω-alkanedicarboxylic acids (DAn, wherenrepresents the number of carbon atoms in the molecule,n= 2–6, 8–11) were designed as homologous additives to interfere with the self-assembly of pimelic acid (DA7) to further induce the form II compound, which differs from form I only in conformation. Interestingly, longer-chain additives (DA6–11) have a stronger form II-inducing ability than short-chain ones (DA2–4). In addition, an apparent gradient of the degree of interference with solute self-assembly, consistent with form II-inducing ability, was detected by infrared and nuclear magnetic resonance spectroscopy. The calculated molecular electrostatic potential charges also clearly indicate that additive–solute electrostatic interactions gradually increase with increasing carbon chain length of the additives, reaching a maximum value with DA6–11. This novel use of additives demonstrates a direct link between solute aggregation and conformational polymorph nucleation.
- 6 February 2021
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 8 (2) , 161-167
Open AccessUse of additives to regulate solute aggregation and direct conformational polymorph nucleation of pimelic acid
Understanding the nucleation pathway and achieving regulation to produce the desired crystals are mutually beneficial. The authors previously proposed a nucleation pathway of conformational polymorphs in which solvation and solute self-assembly could affect the result of the conformational rearrangement and further nucleation outcomes. Based on this, herein α,ω-alkanedicarboxylic acids (DAn, wherenrepresents the number of carbon atoms in the molecule,n= 2–6, 8–11) were designed as homologous additives to interfere with the self-assembly of pimelic acid (DA7) to further induce the form II compound, which differs from form I only in conformation. Interestingly, longer-chain additives (DA6–11) have a stronger form II-inducing ability than short-chain ones (DA2–4). In addition, an apparent gradient of the degree of interference with solute self-assembly, consistent with form II-inducing ability, was detected by infrared and nuclear magnetic resonance spectroscopy. The calculated molecular electrostatic potential charges also clearly indicate that additive–solute electrostatic interactions gradually increase with increasing carbon chain length of the additives, reaching a maximum value with DA6–11. This novel use of additives demonstrates a direct link between solute aggregation and conformational polymorph nucleation.
- 15 April 2020
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (5) , 3173-3181
A New Perspective of Gallic Acid on Calcium Oxalate Nucleation
- 15 April 2020
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (5) , 3173-3181
A New Perspective of Gallic Acid on Calcium Oxalate Nucleation
- Open Access
- 26 March 2020
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 7 (3) , 422-433
Probing the structural pathway of conformational polymorph nucleation by comparing a series of α,ω-alkanedicarboxylic acids
Herein the nucleation pathway of conformational polymorphs was revealed by studying the relationships and distinctions among a series of α,ω-alkanedicarboxylic acids [HOOC–(CH2)n−2–COOH, named DAn, wheren= 5, 7, 9, 11, 13, 15] in the solid state and in solution. Their polymorphic outcomes, with the exception of DA5, show solvent dependence: form I with conformation I crystallizes from solvents with hydrogen-bond donating (HBD) ability, whereas form II with conformation II crystallizes preferentially from solvents with no HBD ability. In contrast, form II of DA5 does not crystallize in any of the solvents used. Quantum mechanical computation showed that there is no direct conformational link between the solvents and the resultant polymorphic outcomes. Surprisingly, solute aggregates were found in no-HBD solvents by Fourier transform infrared spectroscopy, and only monomers could be detected in HBD solvents, suggesting stronger solvation. Furthermore, it was found that all six compounds including DA5 followed the same pattern in solution. Moreover, crystal-packing efficiency calculations and stability tests stated that dimorphs of DA5 bear a greater stability difference than others. These suggest that the rearrangement from conformation II to I could not be limited by hard desolvation in HBD solvents, where form I was also obtained. In other systems, metastable II was produced in the same solvents, probably as a result of the rearrangement being limited by hard desolvation. In this work, a comparative study uncovers the proposed nucleation pathway: difficulty in desolvation has a remarkable effect on the result of rearrangement and nucleation outcome.
- 26 March 2020
- Published by International Union of Crystallography (IUCr) in IUCrJ
- Vol. 7 (3) , 422-433
Open AccessProbing the structural pathway of conformational polymorph nucleation by comparing a series of α,ω-alkanedicarboxylic acids
Herein the nucleation pathway of conformational polymorphs was revealed by studying the relationships and distinctions among a series of α,ω-alkanedicarboxylic acids [HOOC–(CH2)n−2–COOH, named DAn, wheren= 5, 7, 9, 11, 13, 15] in the solid state and in solution. Their polymorphic outcomes, with the exception of DA5, show solvent dependence: form I with conformation I crystallizes from solvents with hydrogen-bond donating (HBD) ability, whereas form II with conformation II crystallizes preferentially from solvents with no HBD ability. In contrast, form II of DA5 does not crystallize in any of the solvents used. Quantum mechanical computation showed that there is no direct conformational link between the solvents and the resultant polymorphic outcomes. Surprisingly, solute aggregates were found in no-HBD solvents by Fourier transform infrared spectroscopy, and only monomers could be detected in HBD solvents, suggesting stronger solvation. Furthermore, it was found that all six compounds including DA5 followed the same pattern in solution. Moreover, crystal-packing efficiency calculations and stability tests stated that dimorphs of DA5 bear a greater stability difference than others. These suggest that the rearrangement from conformation II to I could not be limited by hard desolvation in HBD solvents, where form I was also obtained. In other systems, metastable II was produced in the same solvents, probably as a result of the rearrangement being limited by hard desolvation. In this work, a comparative study uncovers the proposed nucleation pathway: difficulty in desolvation has a remarkable effect on the result of rearrangement and nucleation outcome.
- 24 October 2019
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 64 (12) , 6031-6040
Solid–Liquid Phase Equilibrium and Thermodynamic Analysis of N,N′-Diethylthiourea in Different Solvent Systems
- 24 October 2019
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 64 (12) , 6031-6040
Solid–Liquid Phase Equilibrium and Thermodynamic Analysis of N,N′-Diethylthiourea in Different Solvent Systems
- 1 June 2019
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 284, 547-556
Solid-liquid phase equilibrium and thermodynamic analysis of metal dithiolene complex: The case of zinc dibutyldithiocarbamate
- 1 June 2019
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 284, 547-556
Solid-liquid phase equilibrium and thermodynamic analysis of metal dithiolene complex: The case of zinc dibutyldithiocarbamate
- 9 May 2019
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 21 (24) , 3731-3739
Tuning crystallization and stability of the metastable polymorph of dl-methionine by a structurally similar additive
Crystal engineering is aimed at controlling the crystal forms and desired properties from the view of molecular engineering, which is important for the production of high-value-added products. DL-Methionine (DL-met) usually crystallizes in a concomitant mixture with the known metastable α-form and stable β-form from a pure aqueous solution. In this contribution, we first applied molecular dynamics (MD) simulations to study the effects of the tailor-made additive and found that DL-leucine (DL-leu) might enable us to stabilize the metastable form. To validate our idea, we performed experiments including cooling crystallization with isothermal and non-isothermal methods, nucleation induction time measurements, solvent-mediated phase transformation and crystal growth rate measurements. It was found that on increasing the concentration of DL-leu, the nucleation of the β-form and the transformation of the α-form were hindered. When the concentration of DL-leu reached above 0.02 mol L−1, hexagonal crystals other than foliaceous crystals could be obtained. Hence, the metastable α-form of DL-met with fine crystal habits and high temporal stability was prepared.
- 9 May 2019
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 21 (24) , 3731-3739
Tuning crystallization and stability of the metastable polymorph of dl-methionine by a structurally similar additive
Crystal engineering is aimed at controlling the crystal forms and desired properties from the view of molecular engineering, which is important for the production of high-value-added products. DL-Methionine (DL-met) usually crystallizes in a concomitant mixture with the known metastable α-form and stable β-form from a pure aqueous solution. In this contribution, we first applied molecular dynamics (MD) simulations to study the effects of the tailor-made additive and found that DL-leucine (DL-leu) might enable us to stabilize the metastable form. To validate our idea, we performed experiments including cooling crystallization with isothermal and non-isothermal methods, nucleation induction time measurements, solvent-mediated phase transformation and crystal growth rate measurements. It was found that on increasing the concentration of DL-leu, the nucleation of the β-form and the transformation of the α-form were hindered. When the concentration of DL-leu reached above 0.02 mol L−1, hexagonal crystals other than foliaceous crystals could be obtained. Hence, the metastable α-form of DL-met with fine crystal habits and high temporal stability was prepared.